Butterfly Network, Inc. (BFLY)
| Market Cap | 1.17B +108.3% |
| Revenue (ttm) | 102.92M +20.2% |
| Net Income | -75.77M |
| EPS | -0.30 |
| Shares Out | 261.64M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,262,859 |
| Open | 4.520 |
| Previous Close | 4.480 |
| Day's Range | 4.340 - 4.640 |
| 52-Week Range | 1.320 - 5.720 |
| Beta | 2.28 |
| Analysts | Strong Buy |
| Price Target | 5.69 (+27.29%) |
| Earnings Date | Apr 30, 2026 |
About BFLY
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user’s smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It ... [Read more]
Financial Performance
In 2025, Butterfly Network's revenue was $97.61 million, an increase of 18.96% compared to the previous year's $82.06 million. Losses were -$77.06 million, 6.31% more than in 2024.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for BFLY stock is "Strong Buy." The 12-month stock price target is $5.69, which is an increase of 27.29% from the latest price.
News
Butterfly Network to Participate in the William Blair 46th Annual Growth Stock Conference
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), today announced that the company will participate at the William Blair 46th Annual G...
Butterfly Network Transcript: Bank of America Global Healthcare Conference 2026
Point-of-care ultrasound technology is driving healthcare transformation through digital, AI-enabled devices and cloud integration, with strong adoption and expanding applications. Strategic partnerships and licensing are boosting revenue, while financial performance has significantly improved.
Butterfly Network appoints Caroll Neubauer to board of directors
Butterfly Network (BFLY) announced the appointment of Caroll H. Neubauer to its Board of Directors, effective May 18, 2026. Mr. Neubauer will serve on the Board’s Compensation Committee and Technology...
Butterfly Network Appoints Caroll H. Neubauer to Board of Directors
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud s...
Butterfly Network to Present at the Bank of America Securities 2026 Global Healthcare Conference
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), today announced that the company will participate at the Bank of America Securities ...
Butterfly Network Earnings Call Transcript: Q1 2026
Q1 2026 saw 25% revenue growth, 69% gross margin, and improved EBITDA loss, driven by strong core and embedded business performance. FDA-cleared AI tools, expanding partnerships, and new product launches support a positive outlook, with full-year guidance reaffirmed.
Butterfly Network Earnings release: Q1 2026
Butterfly Network released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Butterfly Network Quarterly report: Q1 2026
Butterfly Network has published its Q1 2026 quarterly earnings report on April 30, 2026.
Butterfly Network reports Q1 EPS (3c), consensus (5c)
Reports Q1 revenue $26.5M, consensus $25.74M. Joseph DeVivo, CEO, commented, “Butterfly opened the year with another strong quarter, coming in above consensus with 25% revenue growth and continued gro...
Butterfly Network still sees FY26 revenue $117M-$121M, consensus $116.62M
Still sees FY26 adjusted EBITDA loss of $21M-$25M.
Butterfly Network sees Q2 revenue $27M-$31M, consensus $28.94M
Sees Q2 adjusted EBITDA loss of $6M-$8M.
Butterfly Network Reports First Quarter 2026 Financial Results
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a pioneer and leader in semiconductor-based ultrasound devices, pro...
Butterfly Network Proxy statement: Proxy filing
Butterfly Network filed a proxy statement on April 27, 2026, providing details for shareholder voting and corporate governance matters.
Butterfly Network Proxy statement: Proxy filing
Butterfly Network filed a proxy statement on April 27, 2026, providing details for shareholder voting and corporate governance matters.
Butterfly Network appoints Arun Nagdev as CMO, POCUS
Butterfly Network (BFLY) announced the appointment of Arun Nagdev, MD as Chief Medical Officer – Point-of-Care Ultrasound. In this role, Dr. Nagdev will lead the global medical strategy for the…
Butterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer – POCUS
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, toda...
Butterfly Network to Report First Quarter 2026 Financial Results on April 30, 2026
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud s...
Butterfly Network gets FDA clearance for AI ultrasound pregnancy tool
Butterfly Network said on Monday it received U.S. regulatory clearance for an artificial intelligence-powered ultrasound tool that can estimate gestational age, a move the company said could expand ...
Butterfly Network receives clearance from U.S. FDA for GA Tool
Butterfly Network (BFLY) announced it has received clearance from the U.S. Food and Drug Administration, FDA, for a fully automated Gestational Age, GA, Tool integrated into its handheld ultrasound so...
Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women's Health
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly,” “the Company”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, progr...
Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud s...
Butterfly Network Transcript: TD Cowen 46th Annual Health Care Conference
Executives highlighted strong progress in handheld ultrasound technology, expanding partnerships, and a robust product pipeline. The embedded business and new AI-driven devices are expected to drive significant growth, with 2026 revenue guidance of $117M-$121M and gross margins above 67%.
Butterfly Network price target raised to $6 from $4.50 at TD Cowen
TD Cowen raised the firm’s price target on Butterfly Network (BFLY) to $6 from $4.50 and keeps a Buy rating on the shares. The firm said they reported strng Q4…
Butterfly Network reports Q4 adjusted EPS (2c), consensus (6c)
Reports Q4 revenue $31.5M vs. $22.35M last year. CEO Joseph DeVivo commented, “Our Q4 2025 performance shows that our strategy is taking hold and our vision is becoming tangible. We…
Butterfly Network Earnings Call Transcript: Q4 2025
Q4 2025 delivered record revenue of $31.5M (+41% YoY), driven by core POCUS growth and the Midjourney Embedded deal. Gross margin rose to 67%, adjusted EBITDA loss improved, and FY 2026 revenue is guided up 20–24%. Butterfly Embedded and home care are key growth drivers.